BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23539877)

  • 1. Tuboovarian abscess. Factors associated with operative intervention after failed antibiotic therapy.
    Greenstein Y; Shah AJ; Vragovic O; Cabral H; Soto-Wright V; Borgatta L; Kuohung W
    J Reprod Med; 2013; 58(3-4):101-6. PubMed ID: 23539877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intrauterine device presence and other factors in medical treatment success of tuboovarian abscess.
    Tugrul Ersak D; Ersak B; Kokanalı MK
    J Gynecol Obstet Hum Reprod; 2021 May; 50(5):101983. PubMed ID: 33189945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the risk factors for developing resistance to parenteral therapy for tubo-ovarian abscess: a case-control study.
    Mizushima T; Yoshida H; Ohi Y; Ishikawa M; Hirahara F
    J Obstet Gynaecol Res; 2013 May; 39(5):1019-23. PubMed ID: 23509912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of neutrophil to lymphocyte ratio in prediction of medical treatment failure for tubo-ovarian abscess.
    Alay I; Kaya C; Karaca I; Eren E; Hosgoren M; Aslanova F; Cengiz H; Ekin M; YaSar L
    J Obstet Gynaecol Res; 2019 Jun; 45(6):1183-1189. PubMed ID: 30907061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image-guided drainage of tuboovarian abscesses of gastrointestinal or genitourinary origin: a retrospective analysis.
    Levenson RB; Pearson KM; Saokar A; Lee SI; Mueller PR; Hahn PF
    J Vasc Interv Radiol; 2011 May; 22(5):678-86. PubMed ID: 21419651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum procalcitonin levels together with clinical features and inflammatory markers in women with tubo-ovarian abscess for discriminating requirements for surgery for full recovery.
    Karaca K; Ozkaya E; Kurek Eken M; Uygun I; Kopuk SY; Alpay M
    J Obstet Gynaecol; 2018 Aug; 38(6):818-821. PubMed ID: 29523046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience of tubo-ovarian abscess in western Turkey.
    Güngördük K; Guzel E; Asicioğlu O; Yildirim G; Ataser G; Ark C; Gulova SS; Uzuncakmak C
    Int J Gynaecol Obstet; 2014 Jan; 124(1):45-50. PubMed ID: 24139472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience of Tubo-Ovarian Abscess: A Retrospective Clinical Analysis of 318 Patients in a Single Tertiary Center in Middle Turkey.
    Inal ZO; Inal HA; Gorkem U
    Surg Infect (Larchmt); 2018 Jan; 19(1):54-60. PubMed ID: 29148955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the serum inflammatory markers for predicting the tubo-ovarian abscess in acute pelvic inflammatory disease: a single-center 5-year experience.
    Demirtas O; Akman L; Demirtas GS; Hursitoglu BS; Yilmaz H
    Arch Gynecol Obstet; 2013 Mar; 287(3):519-23. PubMed ID: 23104053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of ultrasonographic tubo-ovarian abscess morphology in predicting whether patients will require surgical treatment.
    Kinay T; Unlubilgin E; Cirik DA; Kayikcioglu F; Akgul MA; Dolen I
    Int J Gynaecol Obstet; 2016 Oct; 135(1):77-81. PubMed ID: 27381446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the Need for Invasive Intervention in Tubo-ovarian Abscess Be Predicted? The Implication of C-reactive Protein Measurements.
    Ribak R; Schonman R; Sharvit M; Schreiber H; Raviv O; Klein Z
    J Minim Invasive Gynecol; 2020 Feb; 27(2):541-547. PubMed ID: 31479751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is intrauterine device a risk factor for failure of conservative management in patients with tubo-ovarian abscess? An observational retrospective study.
    Kapustian V; Namazov A; Yaakov O; Volodarsky M; Anteby EY; Gemer O
    Arch Gynecol Obstet; 2018 May; 297(5):1201-1204. PubMed ID: 29478102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubo-ovarian abscess in older women: is the woman's age a risk factor for failed response to conservative treatment?
    Halperin R; Levinson O; Yaron M; Bukovsky I; Schneider D
    Gynecol Obstet Invest; 2003; 55(4):211-5. PubMed ID: 12904694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prediction of surgical intervention in patients with tubo-ovarian abscess.
    Hwang JH; Kim BW; Kim SR; Kim JH
    J Obstet Gynaecol; 2022 Jan; 42(1):97-102. PubMed ID: 33629630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis, diagnosis, and management of severe pelvic inflammatory disease and tuboovarian abscess.
    Chappell CA; Wiesenfeld HC
    Clin Obstet Gynecol; 2012 Dec; 55(4):893-903. PubMed ID: 23090458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuboovarian abscesses in postmenopausal women.
    Hsiao SM; Hsieh FJ; Lien YR
    Taiwan J Obstet Gynecol; 2006 Sep; 45(3):234-8. PubMed ID: 17175470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Predictors of Failed Medical Treatment in Patients with Tubo-ovarian Abscess: External Validation of a Recently Published Risk Score.
    Jalloul RJ; Thomas M; Ward C; Pedroza C
    J Minim Invasive Gynecol; 2022 May; 29(5):649-655. PubMed ID: 35051659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and treatment outcomes of patients with tubo-ovarian abscess at a tertiary care hospital in Northern Taiwan.
    Kuo CF; Tsai SY; Liu TC; Lin CC; Liu CP; Lee CM
    J Microbiol Immunol Infect; 2012 Feb; 45(1):58-64. PubMed ID: 22154676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tubo-Ovarian Abscesses: Epidemiology and Predictors for Failed Response to Medical Management in an Asian Population.
    Chan GMF; Fong YF; Ng KL
    Infect Dis Obstet Gynecol; 2019; 2019():4161394. PubMed ID: 31274977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of serum CA 125 for the management of tubo-ovarian abscesses.
    But I; Reljic M
    Wien Klin Wochenschr; 2000 Dec; 112(24):1044-8. PubMed ID: 11204315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.